HK1041688B - 芳基醚的制备方法 - Google Patents

芳基醚的制备方法 Download PDF

Info

Publication number
HK1041688B
HK1041688B HK02103399.9A HK02103399A HK1041688B HK 1041688 B HK1041688 B HK 1041688B HK 02103399 A HK02103399 A HK 02103399A HK 1041688 B HK1041688 B HK 1041688B
Authority
HK
Hong Kong
Prior art keywords
formula
reaction
compound
alkyl
carried out
Prior art date
Application number
HK02103399.9A
Other languages
English (en)
Chinese (zh)
Other versions
HK1041688A1 (en
Inventor
K‧E‧赫尼伽
S‧E‧曼茨尼
K‧D‧麦斯托
K‧D‧麥斯托
Original Assignee
法玛西雅厄普约翰美国公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 法玛西雅厄普约翰美国公司 filed Critical 法玛西雅厄普约翰美国公司
Publication of HK1041688A1 publication Critical patent/HK1041688A1/xx
Publication of HK1041688B publication Critical patent/HK1041688B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/04Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reaction of ammonia or amines with olefin oxides or halohydrins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63Esters of sulfonic acids
    • C07C309/64Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C07C309/66Methanesulfonates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/321,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D301/00Preparation of oxiranes
    • C07D301/02Synthesis of the oxirane ring
    • C07D301/03Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds
    • C07D301/14Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds with organic peracids, or salts, anhydrides or esters thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/14Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by free hydroxyl radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
HK02103399.9A 1998-12-29 1999-12-23 芳基醚的制备方法 HK1041688B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11409298P 1998-12-29 1998-12-29
US60/114,092 1998-12-29
PCT/US1999/030748 WO2000039072A1 (en) 1998-12-29 1999-12-23 Method for the preparation of aryl ethers

Publications (2)

Publication Number Publication Date
HK1041688A1 HK1041688A1 (en) 2002-07-19
HK1041688B true HK1041688B (zh) 2007-12-07

Family

ID=22353332

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02103399.9A HK1041688B (zh) 1998-12-29 1999-12-23 芳基醚的制备方法

Country Status (24)

Country Link
US (1) US6376711B1 (https=)
EP (2) EP1308443B1 (https=)
JP (1) JP2002533430A (https=)
KR (2) KR100616029B1 (https=)
CN (3) CN100340552C (https=)
AT (2) ATE430144T1 (https=)
AU (1) AU764492B2 (https=)
BR (1) BR9916615A (https=)
CA (1) CA2349619A1 (https=)
CO (1) CO5140125A1 (https=)
DE (2) DE69940833D1 (https=)
DK (1) DK1140788T3 (https=)
ES (1) ES2214060T3 (https=)
HK (1) HK1041688B (https=)
HU (1) HUP0202144A3 (https=)
IL (2) IL161840A0 (https=)
NZ (1) NZ511452A (https=)
PE (1) PE20001366A1 (https=)
PT (1) PT1140788E (https=)
SI (1) SI1140788T1 (https=)
TR (1) TR200101885T2 (https=)
TW (1) TWI238155B (https=)
WO (1) WO2000039072A1 (https=)
ZA (1) ZA200103532B (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2796069B3 (fr) 1999-07-09 2001-08-24 Sanofi Synthelabo Nouveaux procedes de preparation de derives de 2-(2- arylmorpholin-2-yl)ethanol substitues, enantiomeriquement purs, et composes intermediaires utiles dans ces procedes
AR030284A1 (es) 2000-06-08 2003-08-20 Merck & Co Inc Proceso para la sintesis de (2r, 2-alfa-r,3a) -2-[1-(3,5-bis(trifluorometil) fenil) etoxi]-3-(4-fluorofenil)-1,4-oxazina; dicho compuesto y sus formas polimorficas
WO2005082869A1 (en) * 2004-02-20 2005-09-09 Pharmacia & Upjohn Company Llc Method for the preparation of aryl ethers
EP1730094A1 (en) * 2004-02-20 2006-12-13 Pharmacia & Upjohn Company LLC Method for the preparation of aryl ethers
WO2005095435A1 (ja) * 2004-03-31 2005-10-13 Kuraray Co., Ltd. プレグナン誘導体の製造方法
BRPI0510453A (pt) 2004-04-30 2007-10-30 Warner Lambert Co composto substituìdos com morfolina para o tratamento de distúrbios do sistema nervoso central
GB0409744D0 (en) * 2004-04-30 2004-06-09 Pfizer Ltd Novel compounds
DK2076508T3 (da) 2006-10-18 2011-02-21 Pfizer Prod Inc Biaryl-ether-urinstof-forbindelser
US20100069389A1 (en) * 2008-09-06 2010-03-18 Bionevia Pharmaceuticals, Inc. Novel forms of reboxetine
CN103804316A (zh) * 2012-11-13 2014-05-21 天津药物研究院 一种(2RS,3RS)-6-[a-(2-乙氧基苯氧基)苄基]吗啉-3-酮(Ⅰ)的制备方法
CN104557936A (zh) * 2015-01-15 2015-04-29 河南科技学院 一种新型手性非环嘌呤核苷类似物的合成方法
US20190381056A1 (en) 2018-06-17 2019-12-19 Axsome Therapeutics, Inc. Compositions for delivery of reboxetine
US20200147093A1 (en) 2018-10-15 2020-05-14 Axsome Therapeutics, Inc. Use of esreboxetine to treat nervous system disorders such as fibromyalgia
US11020402B2 (en) 2018-10-15 2021-06-01 Axsome Therapeutics, Inc. Use of reboxetine to treat narcolepsy
US12565478B1 (en) 2025-01-21 2026-03-03 Axsome Therapeutics, Inc. (S)-2-((S)-(2-ethoxyphenoxy)(phenyl)methyl)-4-nitrosomorpholine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2785185A (en) * 1952-08-07 1957-03-12 Union Carbide & Carbon Corp Process for making oxirane compounds from olefins and aldehyde monoperacylates
GB1053972A (https=) * 1962-08-30 1967-01-04
IL56369A (en) 1978-01-20 1984-05-31 Erba Farmitalia Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
GB8419683D0 (en) * 1984-08-02 1984-09-05 Erba Farmitalia 3-substituted derivatives of 1-amino-2-hydroxy-propane

Also Published As

Publication number Publication date
HK1078572A1 (zh) 2006-03-17
EP1308443A2 (en) 2003-05-07
EP1140788B1 (en) 2004-02-25
DE69915110D1 (de) 2004-04-01
IL144012A0 (en) 2002-04-21
US6376711B1 (en) 2002-04-23
TWI238155B (en) 2005-08-21
CN1332719A (zh) 2002-01-23
HUP0202144A2 (hu) 2002-11-28
ES2214060T3 (es) 2004-09-01
KR20060090310A (ko) 2006-08-10
EP1308443A3 (en) 2003-10-01
IL161840A0 (en) 2005-11-20
PT1140788E (pt) 2004-07-30
CA2349619A1 (en) 2000-07-06
CN1636988A (zh) 2005-07-13
SI1140788T1 (en) 2004-08-31
EP1140788A1 (en) 2001-10-10
NZ511452A (en) 2002-11-26
BR9916615A (pt) 2001-10-23
WO2000039072A1 (en) 2000-07-06
PE20001366A1 (es) 2000-11-19
DK1140788T3 (da) 2004-06-07
CO5140125A1 (es) 2002-03-22
EP1308443B1 (en) 2009-04-29
ATE430144T1 (de) 2009-05-15
DE69915110T2 (de) 2004-08-26
JP2002533430A (ja) 2002-10-08
HK1066004A1 (en) 2005-03-11
DE69940833D1 (de) 2009-06-10
TR200101885T2 (tr) 2002-01-21
CN1308332C (zh) 2007-04-04
ZA200103532B (en) 2002-08-02
AU764492B2 (en) 2003-08-21
KR20010099999A (ko) 2001-11-09
IL144012A (en) 2005-11-20
CN1249038C (zh) 2006-04-05
KR100616029B1 (ko) 2006-08-28
AU2381900A (en) 2000-07-31
KR100616386B1 (ko) 2006-08-28
ATE260238T1 (de) 2004-03-15
HUP0202144A3 (en) 2003-10-28
HK1041688A1 (en) 2002-07-19
CN1532194A (zh) 2004-09-29
CN100340552C (zh) 2007-10-03

Similar Documents

Publication Publication Date Title
CN1308332C (zh) 芳基醚的制备方法
CN1305853C (zh) Hmg辅酶a还原酶抑制剂的制备方法
CN1553915A (zh) 制备六氢-呋喃并[2,3-b]呋喃-3-醇的方法
CN1119321C (zh) 手性β-氨基酸的不对称合成
CN1482908A (zh) 吲哚并咔唑的相转移催化苷化方法
CN1082046C (zh) 2-(2-羟甲基苯基)乙酰胺衍生物的制备方法及其制备用中间体
HK1078572B (en) Method for the preparation of aryl ethers
HK1066004B (en) Method for the preparation of aryl ethers
CN1146554C (zh) 非甾体抗雌激素的对映体选择性合成
CN1360574A (zh) 制备三环氨基醇衍生物的方法
CN1221505C (zh) 制备链烷二醇衍生物方法
CN100344617C (zh) 一种四氮唑类化合物的化学合成方法
CN1990450A (zh) 前列腺素f型衍生物的制造方法及新颖中间体
CN1922166A (zh) 3-氨基-5-(羟甲基)环戊烷-1,2-二醇衍生物的生产方法
CN1013443B (zh) 制备咪唑衍生物的方法
CN1379748A (zh) 旋光α-羟基酸和其衍生物的制备方法
HK1099301A (en) Method for the production of 3-amino-5-(hydroxymethyl)cyclopentane-1,2-diol derivatives
CN1922124A (zh) 制备芳基醚的方法
HK1019874B (en) Asymetric synthesis of chiral beta-amino acids
HK1103545A (en) Method for the preparation of aryl ethers
CN1095062A (zh) 取代的吡咯烷-2-酮的纯对映异构体制备方法
HK1019226A (en) Process to prepare taxol

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)